[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100624780":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":11,"centralContacts":25,"locations":32,"responsibleParty":49,"collaborators":11,"id":53,"slug":11,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":60,"sex":61,"minAge":62,"maxAge":11,"enrollmentInfo":63,"targetDuration":11,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":11,"overallStatus":72,"whyStopped":11,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Assiut University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Group(1)","EXPERIMENTAL",null,[13,14],"Diagnostic Test: Serum level of Human Talin-1","Diagnostic Test: Serum level of Human Cripto-1",[16,21],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":11},"DIAGNOSTIC_TEST","Serum level of Human Talin-1","To evaluate the clinical utility of Talin-1 measurement in colorectal cancer patients in comparison with healthy controls.",[9],{"type":17,"name":22,"description":23,"armGroupLabels":24,"otherNames":11},"Serum level of Human Cripto-1","To evaluate the clinical utility of Cripto-1 measurement in colorectal cancer patients in comparison with healthy controls.",[9],[26],{"name":27,"role":28,"phone":29,"phoneExt":30,"email":31},"Sherouk Ahmed Sayed, Assistant lecturer","CONTACT","+201123232632","+201009922949","shrookabozaid@gmail.com",[33],{"facility":34,"status":11,"city":35,"state":36,"zip":37,"country":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Assuit University Hospital","Asyut","Asyut Governorate","17777","Egypt",{"type":40,"coordinates":41},"Point",[42,43],31.18368,27.18096,{"lat":43,"lon":42},[46],{"name":47,"role":28,"phone":48,"phoneExt":11,"email":11},"Sherouk Ahmed","01123232632",{"type":50,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Shrook S. Ahmed","Assistant lecturer","100624780",false,"NCT07414082","Serum Talin-1 and Cripto-1 in Colorectal Cancer","Evaluating Serum Talin-1 and Cripto-1 as Diagnostic Biomarkers in Colorectal Cancer","Talin-1\u002FCR-1","Inclusion Criteria:\n\n* Age \\>18 years Old.\n* Patients of both sexes who met the clinical diagnostic criteria of colorectal cancer (change in bowel habit, absolute or recurrent constipation, rectal bleeding, significant weight loss or intestinal obstruction)\n* Patients diagnosed with colorectal cancer by imaging and histopathology\n\nExclusion Criteria:\n\n* Age \\\u003C18 years old.\n* Patients with past history of chemotherapy or surgical excision of tumor\n* Patients with familial adenomatous polyposis\n* Patients with hereditary non-polyposis colorectal cancer\n* Patients with inflammatory bowel disease\n* patients with other types of tumors",true,"ALL","18 Years",{"count":64,"type":65},70,"ESTIMATED","INTERVENTIONAL",[68],"NA","The goals of this study are\n\n* To evaluate the clinical utility of Talin-1 and Cripto-1 measurement in colorectal cancer patients in comparison with healthy controls.\n* To Compare the diagnostic significance of serum Talin-1 and Cripto-1 with traditional serum biomarker CEA",[71],"Colo-rectal Cancer","NOT_YET_RECRUITING","2026-02-12",{"date":75,"type":76},"2026-02-17","ACTUAL",{"date":78,"type":65},"2026-03-30",{"date":80,"type":65},"2029-12-31",{"name":5,"class":6},1]